The on-demand webinar and Q&A “Large-Scale LVV Production: From Industry-Leading Process Development to High Quality GMP Vector,” with our own Giuliana Vallanti, Director of Development and Global R&D, Cell and Gene Therapy, and the panel of co-hosts is now available to watch for free.
On-Demand Webinar: Large-Scale LVV Production: Industry-Leading Process Development to High Quality GMP Vector
by David Self Published on 2/25/21 12:00 PM Thought Leadership, Cell & Gene Therapy
Learn More
On-Demand Roundtable: Streaming and Optimizing Viral Vector Bioprocess and Analytical Development
by David Self Published on 1/15/21 10:38 AM Thought Leadership, Cell & Gene Therapy
Join AGC Biologics' own Mark Womack, Chief Business Officer and Ramin Baghirzade, Sr. Director and Global Cell and Gene Therapy (C>) Business Development, and a panel of co-hosts for an on-demand presentation of the C> Expert Roundtable on Streaming and Optimizing Viral Vector Bioprocess and Analytical Development, presented by BioInsights.
Video: BIO-Europe 2020 Presentation: AGC Biologics' Capabilities and Introduction to Cell and Gene Therapy
by David Self Events, Thought Leadership, Cell & Gene Therapy
Byron Kneller, VP, Process Development, Seattle and Luca Alberici, General Manager, Milan, present AGC Biologics’ end-to-end CDMO protein expression and cell and gene therapy manufacturing capabilities at BIO-Europe in October, 2020.
Article: Process Development: How to Win the Race in Cell & Gene Therapy
by David Self Published on 10/6/20 11:24 AM Thought Leadership, Cell & Gene Therapy
In this spotlight article, presented by BioInsights, Dr. Ramin Baghirzade, AGC Biologics' Global Head of Business Development for Cell & Gene Therapy, shares his expert insights on the state of the industry, and four inter-connected variables exerting pressure on therapeutics developers to improve their processes earlier in the product’s development.
Follow Us
